| Mr Jayant Manilal Chheda, | |
|
2394 25th St, Columbus, IN 47201-3719 | |
| (812) 372-8274 | |
| Not Available |
| Full Name | Mr Jayant Manilal Chheda |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2394 25th St, Columbus, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467715946 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26022200A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jayant Manilal Chheda, 7485 Elmbury Ct, Indianapolis, IN 46237-8327 Ph: (317) 345-4229 | Mr Jayant Manilal Chheda, 2394 25th St, Columbus, IN 47201-3719 Ph: (812) 372-8274 |
News Archive
ARIAD Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at $3.70 per share. The offering is expected to close on or about October 29, 2010, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,400,000 shares of common stock to cover over-allotments, if any.
Clementia Pharmaceuticals, Inc. today announced the initiation of enrollment of children as young as 6 years old in the company's ongoing Phase 2 study of palovarotene for the treatment of fibrodysplasia ossificans progressiva (FOP).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.
Cerapedics, a privately-held orthobiologics company, today announced closing of a $4 million term loan from GE Capital, Healthcare Financial Services, bringing the total facility to $16.5 million. The company also announced it recently raised an additional $4 million in equity financing from inside investors.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
› Verified 4 days ago
Mrs. Carol Joy Meyer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2140 W Jonathan Moore Pike, Columbus, IN 47201 Phone: 812-378-0804 Fax: 812-378-2078 | |
Jessica Rae Fogle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2423 N National Rd, Columbus, IN 47201 Phone: 812-372-7804 Fax: 812-378-3790 | |
Mrs. Kim Volland Littrell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2025 Merchant Mile, Columbus, IN 47201 Phone: 812-376-9385 | |
Jeff E Blasdel, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2140 W Jonathan Moore Pike, Columbus, IN 47201 Phone: 812-378-0804 Fax: 812-378-2078 | |
Amber Dawn Stringer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3060 N National Rd, Columbus, IN 47201 Phone: 812-376-9566 Fax: 812-378-8626 | |
Heather Lewis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3060 N National Rd, Columbus, IN 47201 Phone: 812-376-9566 Fax: 812-378-8628 | |
Kathleen Marie Shafer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2400 Beam Rd, Columbus, IN 47203 Phone: 812-378-4701 Fax: 812-376-9582 |